Pharmacoeconomic moh program 1
-
Upload
noura-aljohani -
Category
Health & Medicine
-
view
57 -
download
9
Transcript of Pharmacoeconomic moh program 1
![Page 1: Pharmacoeconomic moh program 1](https://reader034.fdocuments.us/reader034/viewer/2022042522/55a830881a28aba3318b4781/html5/thumbnails/1.jpg)
Norah Al JohanyHead of Pharmacoeconomic department General administration of pharmaceutical [email protected]
Pharmacoeconomic PROGRAM 1
![Page 2: Pharmacoeconomic moh program 1](https://reader034.fdocuments.us/reader034/viewer/2022042522/55a830881a28aba3318b4781/html5/thumbnails/2.jpg)
70Pharmacists
4 Pharmacists
![Page 3: Pharmacoeconomic moh program 1](https://reader034.fdocuments.us/reader034/viewer/2022042522/55a830881a28aba3318b4781/html5/thumbnails/3.jpg)
Pharmacoeconomic Analysis of DPIC InquiriesLevel ($) Description ($) Cost 95% CI
0 No medication-related problems 0 NA
1 No change in therapy or no harm 0 NA
2 Physician visit 64.50 NA
3a Additional tests 95.00 73-116
3b Non-invasive procedure 184.00 120-248
4a Additional treatment 227.00 147-306
4b Additional treatment/ non-invasive procedure 411.00 267-554
4c Increased length of stay/ invasive procedure 2505.00 1569-3441
4d Increased length of stay 2598.00 1471-3722
5a Transfer to ICU 2640.00 1471-3808
5b Transfer to ICU/invasive procedure 5145.00 3040-7249
5c Long-term care admission 4571.47 NA
6 Death 100,000.00 NA
![Page 4: Pharmacoeconomic moh program 1](https://reader034.fdocuments.us/reader034/viewer/2022042522/55a830881a28aba3318b4781/html5/thumbnails/4.jpg)
Example
• Dr prescribe Denosumab for my 50 y old mother I want complete drug information
• If I did not answer the question what will happen ?
![Page 5: Pharmacoeconomic moh program 1](https://reader034.fdocuments.us/reader034/viewer/2022042522/55a830881a28aba3318b4781/html5/thumbnails/5.jpg)
• The use of dentinox for my 1 w y old doter
![Page 6: Pharmacoeconomic moh program 1](https://reader034.fdocuments.us/reader034/viewer/2022042522/55a830881a28aba3318b4781/html5/thumbnails/6.jpg)
Total Cost Saving = 139155 $ / one month
![Page 7: Pharmacoeconomic moh program 1](https://reader034.fdocuments.us/reader034/viewer/2022042522/55a830881a28aba3318b4781/html5/thumbnails/7.jpg)
Pharmacists intervention cost
![Page 8: Pharmacoeconomic moh program 1](https://reader034.fdocuments.us/reader034/viewer/2022042522/55a830881a28aba3318b4781/html5/thumbnails/8.jpg)
Part 2
![Page 9: Pharmacoeconomic moh program 1](https://reader034.fdocuments.us/reader034/viewer/2022042522/55a830881a28aba3318b4781/html5/thumbnails/9.jpg)
• Saudi Arabian healthcare budget seen to surge 74% with (4.550.000.000) billion riyals approved amount budget for medicines and medical supplies
• So we have to Respond to society’s question: “Are we receiving the greatest benefit for our health care riyals?”
• With the Growing number of alternatives Need for efficiency and Rising health care cost
Need for Pharmacoeconomic in the ministry of health
![Page 10: Pharmacoeconomic moh program 1](https://reader034.fdocuments.us/reader034/viewer/2022042522/55a830881a28aba3318b4781/html5/thumbnails/10.jpg)
Ministry of healthKingdom of Saudi ArabiaPharmacoeconomic Manual
![Page 11: Pharmacoeconomic moh program 1](https://reader034.fdocuments.us/reader034/viewer/2022042522/55a830881a28aba3318b4781/html5/thumbnails/11.jpg)
Formulary management • Clinical decisions – drug selection at patient level• Drug policy • MOH Program management • Resource allocation • Purchase negotiation
Decisions supported by pharmacoeconomic studies
![Page 12: Pharmacoeconomic moh program 1](https://reader034.fdocuments.us/reader034/viewer/2022042522/55a830881a28aba3318b4781/html5/thumbnails/12.jpg)
•It is the policy of the Pharmacoeconomic center to do intensive analysis, for all new drug need to be add on the formulary and having evidence for using reported pharmacoeconomics data to improve medication use process and reduce cost rate properly
•It is the policy of the Pharmacoeconomic center to calculate Calculation the cost benefit for MOH program
Policy
![Page 13: Pharmacoeconomic moh program 1](https://reader034.fdocuments.us/reader034/viewer/2022042522/55a830881a28aba3318b4781/html5/thumbnails/13.jpg)
•Filling the Pharmacoeconomic MOH Forms for DUE•Pharmacoeconomic Literature Evaluation •Quality of life measuring tool•Assessment tool of medication compliance and persistence)•calculation adverse drug reaction •Calculation the cost benefit for MOH program
Procedures
![Page 14: Pharmacoeconomic moh program 1](https://reader034.fdocuments.us/reader034/viewer/2022042522/55a830881a28aba3318b4781/html5/thumbnails/14.jpg)
•To change the misunderstanding of of the Pharmacoeconomic concepts in the ministry of health (NOT DIRECT PRICE) •Cost does not equal the price of a product
Ministry of health Pharmacoeconomic Principles
![Page 15: Pharmacoeconomic moh program 1](https://reader034.fdocuments.us/reader034/viewer/2022042522/55a830881a28aba3318b4781/html5/thumbnails/15.jpg)
Decisions makers pharmacist and healthcare provider in the MOH must understand • The Criteria for evaluating pharmaceuticals are safety +efficacy +value • Pharmacoeconomic analysis includes all costs associated with an intervention• How to use the Pharmacoeconomic tools in Decision making
Goal
![Page 16: Pharmacoeconomic moh program 1](https://reader034.fdocuments.us/reader034/viewer/2022042522/55a830881a28aba3318b4781/html5/thumbnails/16.jpg)
•It is the policy of the Pharmacoeconomic center to provide training and service programs to enhance the application of economic and effectiveness measures to the practice of health care and the management of health systems
Policy
![Page 17: Pharmacoeconomic moh program 1](https://reader034.fdocuments.us/reader034/viewer/2022042522/55a830881a28aba3318b4781/html5/thumbnails/17.jpg)
Part 3
![Page 18: Pharmacoeconomic moh program 1](https://reader034.fdocuments.us/reader034/viewer/2022042522/55a830881a28aba3318b4781/html5/thumbnails/18.jpg)
•Purpose ?•How
Ministry of health Pharmacoeconomic Research
![Page 19: Pharmacoeconomic moh program 1](https://reader034.fdocuments.us/reader034/viewer/2022042522/55a830881a28aba3318b4781/html5/thumbnails/19.jpg)
Drug Related Problems Program forms to calculate the cost of Medication Errors Adverse drug reaction
Filling Pharmacoeconomic MOH data collection forms
![Page 20: Pharmacoeconomic moh program 1](https://reader034.fdocuments.us/reader034/viewer/2022042522/55a830881a28aba3318b4781/html5/thumbnails/20.jpg)
•DPIC Inquiries Program•Drug evaluation scoring•Pharmacist intervention cost of avoidance
Cost analysis
![Page 21: Pharmacoeconomic moh program 1](https://reader034.fdocuments.us/reader034/viewer/2022042522/55a830881a28aba3318b4781/html5/thumbnails/21.jpg)
![Page 22: Pharmacoeconomic moh program 1](https://reader034.fdocuments.us/reader034/viewer/2022042522/55a830881a28aba3318b4781/html5/thumbnails/22.jpg)
Part 4
![Page 23: Pharmacoeconomic moh program 1](https://reader034.fdocuments.us/reader034/viewer/2022042522/55a830881a28aba3318b4781/html5/thumbnails/23.jpg)
•Participates in Conferences and exhibitions and forums•Subscriptions books and scientific journals and special pharmacoeconomic educational materials
Establishes Pharmacoeconomic specialist pharmacist program